Shukra [SHUKRAPHAR] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison

Shukra

BSE
Loading...

Sequent Scientific

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Shukra wins in 9 metrics, Sequent Scientific wins in 10 metrics, with 0 ties. Sequent Scientific appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricShukraSequent ScientificBetter
P/E Ratio (TTM)275.85166.33Sequent Scientific
Price-to-Book Ratio25.616.61Sequent Scientific
Debt-to-Equity Ratio6.6562.47Shukra
PEG Ratio3.371.40Sequent Scientific
EV/EBITDA100.3530.63Sequent Scientific
Profit Margin (TTM)25.68%1.85%Shukra
Operating Margin (TTM)25.25%7.56%Shukra
EBITDA Margin (TTM)25.25%7.56%Shukra
Return on Equity15.24%2.84%Shukra
Return on Assets (TTM)11.04%1.37%Shukra
Free Cash Flow (TTM)$51.75M$442.73MSequent Scientific
Dividend Yield3.20%N/AN/A
1-Year Return364.29%-10.14%Shukra
Price-to-Sales Ratio (TTM)39.853.00Sequent Scientific
Enterprise Value$18.02B$50.87BSequent Scientific
EV/Revenue Ratio45.743.17Sequent Scientific
Gross Profit Margin (TTM)85.71%46.86%Shukra
Revenue per Share (TTM)$1$64Sequent Scientific
Earnings per Share (Diluted)$0.13$1.12Sequent Scientific
Beta (Stock Volatility)0.320.91Shukra
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Shukra vs Sequent Scientific Stock Performance Analysis

Loading Price Chart...

Shukra
Sequent Scientific
Shukra Stock Overview | Sequent Scientific Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Shukra-1.99%-0.09%23.88%107.66%67.40%140.74%
Sequent Scientific1.15%-8.42%9.29%-3.35%37.17%0.89%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Shukra364.29%579.49%2,326.06%2,066.67%828.57%828.57%
Sequent Scientific-10.14%69.59%19.72%26.36%26.36%26.36%

News Based Sentiment: Shukra vs Sequent Scientific

Shukra

News based Sentiment: MIXED

September presented a mixed bag for Shukra Pharmaceuticals. While the company achieved a new 52-week high and secured a significant distribution partnership with Wockhardt, it also reported a substantial revenue contraction in FY25. The upcoming warrant issue adds another layer of complexity, making it a pivotal month for the company's future direction.

View Shukra News Sentiment Analysis

Sequent Scientific

News based Sentiment: POSITIVE

Sequent Scientific's impressive Q1 FY2025-26 results, with a 21.9% revenue increase and a massive 1283.5% profit jump, clearly demonstrate a positive shift in the company's financial performance. This strong showing is a significant development for investors, indicating potential for future growth and returns.

View Sequent Scientific News Sentiment Analysis

Performance & Financial Health Analysis: Shukra vs Sequent Scientific

MetricSHUKRAPHARSEQUENT
Market Information
Market Cap i₹16.02B₹48.13B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i110,1131,494,055
90 Day Avg. Volume i340,504754,164
Last Close₹34.45₹186.29
52 Week Range₹5.75 - ₹35.86₹117.35 - ₹240.70
% from 52W High-3.93%-22.60%
All-Time High₹35.86 (Sep 30, 2025)₹336.50 (Jun 28, 2021)
% from All-Time High-3.93%-44.64%
Growth Metrics
Quarterly Revenue Growth0.67%0.13%
Quarterly Earnings Growth1.12%1.20%
Financial Health
Profit Margin (TTM) i0.26%0.02%
Operating Margin (TTM) i0.25%0.08%
Return on Equity (TTM) i0.15%0.03%
Debt to Equity (MRQ) i6.6562.47
Cash & Liquidity
Book Value per Share (MRQ)₹1.40₹28.19
Cash per Share (MRQ)₹0.24₹2.52
Operating Cash Flow (TTM) i₹66.80M₹360.47M
Levered Free Cash Flow (TTM) i₹95.75M₹218.78M
Dividends
Last 12-Month Dividend Yield i3.20%N/A
Last 12-Month Dividend i₹1.02₹0.00

Valuation & Enterprise Metrics Analysis: Shukra vs Sequent Scientific

MetricSHUKRAPHARSEQUENT
Price Ratios
P/E Ratio (TTM) i275.85166.33
Forward P/E iN/A36.89
PEG Ratio i3.371.40
Price to Sales (TTM) i39.853.00
Price to Book (MRQ) i25.616.61
Market Capitalization
Market Capitalization i₹16.02B₹48.13B
Enterprise Value i₹18.02B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i45.743.17
Enterprise to EBITDA i100.3530.63
Risk & Other Metrics
Beta i0.320.91
Book Value per Share (MRQ) i₹1.40₹28.19

Financial Statements Comparison: Shukra vs Sequent Scientific

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SHUKRAPHARSEQUENT
Revenue/Sales i₹53.91M₹4.41B
Cost of Goods Sold i₹7.70M₹2.35B
Gross Profit i₹46.21M₹2.07B
Research & Development iN/AN/A
Operating Income (EBIT) i₹5.32M₹333.50M
EBITDA i₹24.28M₹505.30M
Pre-Tax Income i₹13.73M₹255.20M
Income Tax i₹3.44M₹79.50M
Net Income (Profit) i₹10.30M₹175.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SHUKRAPHARSEQUENT
Cash & Equivalents i₹121.18M₹626.60M
Total Current Assets i₹654.27M₹8.74B
Total Current Liabilities i₹172.84M₹5.05B
Long-Term Debt i₹31.13M₹3.00B
Total Shareholders Equity i₹628.36M₹7.70B
Retained Earnings i₹143.00M₹1.25B
Property, Plant & Equipment i₹193.97M₹2.84B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SHUKRAPHARSEQUENT
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSHUKRAPHARSEQUENT
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i110,1131,494,055
Average Daily Volume (90 Day) i340,504754,164
Shares Outstanding i437.88M249.89M
Float Shares i54.95M118.88M
% Held by Insiders i0.89%0.52%
% Held by Institutions i0.00%0.13%

Dividend Analysis & Yield Comparison: Shukra vs Sequent Scientific

MetricSHUKRAPHARSEQUENT
Last 12-Month Dividend i₹1.02₹0.00
Last 12-Month Dividend Yield i3.20%N/A
3-Year Avg Annual Dividend i₹0.35₹0.00
3-Year Avg Dividend Yield i3.91%N/A
3-Year Total Dividends i₹1.05₹0.00
Ex-Dividend DateSep 23, 2025N/A